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INTRODUCTION
Duane retraction syndrome (DRS) is the most common of the congenital cranial dysinnervation disorders with a prevalence of 1:1000 (Engle, 2010) . Affected individuals have unilaterally or bilaterally limited eye abduction and globe retraction with attempted eye adduction. Postmortem brainstem and orbital examination of two adults (Hotchkiss et al., 1980; Miller et al., 1982) and magnetic resonance imaging of four patients (Demer et al., 2007) with DRS revealed absence or hypoplasia of the abducens nerve, which normally innervates the lateral rectus (LR) extraocular muscle to abduct the eye, and were consistent with aberrant LR muscle innervation by axons of the oculomotor nerve, which normally innervates the medial rectus (MR), inferior rectus (IR), superior rectus (SR), and inferior oblique (IO) extraocular muscles. Electromyographic studies of 3 DRS record co-contraction of the LR muscle with the MR muscle, and less frequently cocontraction of the LR muscle with the IR or SR muscles (Huber, 1974; Strachan and Brown, 1972) . However, development of aberrant branches of the oculomotor nerve in the absence of the abducens nerve have not been documented in vivo, and it is unknown whether aberrant branching results from primary pathology in the oculomotor nerve, or is secondary to abducens nerve hypoplasia.
In this study, we report MAFB as a human DRS disease gene. The mouse Mafb (Krml1) encodes a transcription factor of the basic leucine zipper family (Kataoka et al., 1994) . Previous studies have shown that Mafb is required for proper hindbrain segmentation (Cordes and Barsh, 1994; McKay et al., 1994) , and regulates other transcription factors involved in hindbrain patterning, such as Hoxb3 (Manzanares et al., 1997) . Mafb has also been shown to play a role in the differentiation of kidney podocytes (Sadl et al., 2002) , macrophages (Aziz et al., 2009) , and α and β cells in the pancreas (Artner et al., 2007; Artner et al., 2006) . Here, we identify haploinsufficient and dominant negative MAFB mutations in patients with DRS and propose a threshold model for loss of MAFB function causing DRS and inner ear defects. We also demonstrate that Mafb knockout mice recapitulate human DRS pathology and can serve as an effective disease model, and establish that the aberrant branching of the oculomotor nerve in DRS is secondary to disruptions of abducens nerve development. Our findings broaden our understanding of the etiology of DRS and suggest that both environmental and genetic insults to the abducens nerve in early development can cause this disorder.
RESULTS

Mutations in MAFB cause Duane retraction syndrome
We enrolled a dominant pedigree FA that segregated DRS together with congenital hearing loss ( Figure 1A) . Affected members of this pedigree had clinical DRS and inner ear common cavity anomalies ( Figure 1B and 1C) . The inner ear defects suggested a disruption of hindbrain development similar to that previously reported in patients with HOXA1 mutations and in
Mafb
KO/KO mice (Tischfield et al., 2005; Yu et al., 2013) . Affected members did not harbor a HOXA1 mutation. Thus, we screened MAFB in this pedigree and in an additional 410 DRS probands for exonic mutations and copy number variations (Table S1 ). We identified heterozygous single base pair frameshift deletions in pedigrees FA (de novo), 0819 (de novo),
and PM, and a heterozygous full gene deletion in pedigree N ( Figure 1A , Figure S1 and S2).
These MAFB variants were not present in the ExAC database. Notably, the affected individual in pedigree 0819 represents the first reported case of a de novo genetic mutation causing nonsyndromic simplex DRS. Unlike pedigree FA, affected members of pedigrees 0819, PM, and N had isolated DRS with no hearing loss ( Table 1) .
Mafb knockout mice model DRS pathogenesis
To examine whether loss of MAFB causes DRS in vivo, we studied Mafb knockout mice (Yu et al., 2013) . At E11.5, Mafb WT/WT embryos have normal hindbrain and cranial nerve development (Figure 2A and 2D) . Mafb WT/KO embryos have hypoplastic abducens nerves but otherwise normal hindbrain development ( Figure 2B and 2E) . Mafb KO/KO embryos do not develop rhombomeres 5 and 6, and as a result have absent abducens nerves and fusion of the glossopharyngeal and vagus nerves ( Figure 2C and 2F).
Using a novel orbital dissection technique, we observe that by E12.5, in Mafb WT/WT embryos the abducens nerve is present in the orbit and contacts the developing LR muscle ( Figure 2G ). In Mafb WT/KO embryos a hypoplastic abducens nerve contacts the developing LR muscle, but an aberrant branch of the oculomotor nerve also begins to form in the direction of the LR muscle ( Figure 2H ). In Mafb KO/KO embryos the abducens nerve is absent, and an aberrant branch of the oculomotor nerve forms and contacts the developing LR muscle along a similar trajectory as the wildtype abducens nerve ( Figure 2I ). This aberrant branch arises from a decision region of the oculomotor nerve where it branches into its superior and inferior divisions (Cheng et al., 2014) .
By E13.5, in Mafb WT/WT embryos the abducens nerve and LR muscle continue to develop, and there are no aberrant branches from the oculomotor nerve ( Figure 2J ). In Mafb WT/KO embryos the hypoplastic abducens nerve remains in contact with the LR muscle, and the oculomotor nerve forms additional aberrant branches towards the LR muscle ( Figure 2K ). In Mafb KO/KO embryos the oculomotor nerve forms a clear distal aberrant branch in addition to the more proximal aberrant branch that formed at E12.5 ( Figure 2L ). The distal aberrant branch arises from a second decision region where the oculomotor inferior division further branches to innervate the MR muscle, the inferior rectus (IR) muscle, and the inferior oblique (IO) muscle.
By E16.5, Mafb WT/WT embryos have developed the adult configuration of the extraocular muscles (EOMs) and cranial nerves in the orbit ( Figure 2M ). In Mafb WT/KO embryos the abducens nerve remains hypoplastic, and the LR muscle is innervated both by the hypoplastic abducens nerve and by aberrant branches of the oculomotor nerve ( Figure 2N ). In Mafb KO/KO embryos the LR muscle is innervated by two distinct aberrant branches of the oculomotor nerve, one smaller 6 proximal branch and one larger distal branch ( Figure 2O ). The distal aberrant branch always appears larger than the proximal aberrant branch.
Our findings confirm human DRS pathology in an animal model for the first time, and broaden our understanding of the developmental mechanism of DRS. Knocking out Mafb selectively disrupts abducens nerve development, since Mafb expression is restricted to rhombomeres 5 and 6 in early development and is not found in developing midbrain oculomotor neurons (Cordes and Barsh, 1994; Giudicelli et al., 2003; Kim et al., 2005; Sadl et al., 2003) . Thus, the DRS pathology in Mafb knockout mice demonstrates that the aberrant innervation of the LR muscle by the oculomotor nerve arises secondarily to absent or reduced LR muscle innervation by the abducens nerve.
Loss of MAFB function below a 50% threshold causes both DRS and inner ear defects
We next investigated whether DRS and hearing loss in pedigree FA shared a common etiology.
We hypothesized that pedigree FA harbored a heterozygous dominant-negative MAFB mutation that caused the more severe phenotype of DRS with hearing loss, while the pedigrees with isolated DRS had heterozygous loss-of-function mutations that resulted in haploinsufficiency.
This hypothesis was supported by HOXA1 patients who have both DRS and inner ear defects (Tischfield et al., 2005) , and by Mafb KO/KO mice, which also have inner ear defects (Yu et al., 2013) . Further support comes from kreisler (kr) mice (Hertwig, 1942) , which harbor a hypomorphic Mafb allele (Eichmann et al., 1997; Sing et al., 2009) . kr/+ mice have normal inner ear and abducens nerve development, while kr/kr mice have inner ear defects and absent abducens nerves (Cordes and Barsh, 1994; Deol, 1964; McKay et al., 1994 (Kataoka et al., 1994; Kerppola and Curran, 1994) . The frameshift mutation in pedigree 0819
occurs between the N-terminal polyhistidine regions, and is predicted to result in a mutant MAFB protein that retains the first polyhistidine region followed by 77 altered amino acids, truncating at a new stop codon ( Figure 3A) . The frameshift mutation in pedigree PM occurs at the beginning of the EHR, and is predicted to result in a mutant MAFB protein that retains the first 3 amino acids of the EHR followed by 8 altered amino acids, truncating at the same stop codon as the 0819-mutant MAFB ( Figure 3A) . Since the 0819-mutant MAFB protein lacks the EHR, BR, and LZ domains, and the PM-mutant MAFB protein lacks most of the EHR and all of the BR and LZ domains, both are predicted to have no dimerization or DNA binding function. In contrast, the frameshift mutation in pedigree FA occurs in the LZ, and is predicted to result in a mutant MAFB protein that retains the EHR, BR, and first leucine of the LZ, followed by 125 altered amino acids ( Figure 3A) .
We found expression of the FA-mutant MAFB mRNA in FA patient-derived lymphoblasts (Table S2 , Figure S3 ), and we successfully overexpressed FA-and 0819-mutant MAFB constructs in vitro ( Figure S4) . We measured the transcriptional activity of wildtype, FA-mutant, and 0819-mutant MAFB proteins by luciferase assay and found no activity in either mutant alone ( Figure 3B) . We then co-expressed wildtype MAFB with each mutant and found that FA-mutant MAFB, but not 0819-mutant MAFB, reduced the transcriptional activity of the wildtype protein 8 ( Figure 3B) . These data support a heterozygous dominant-negative mechanism for FA-mutant MAFB, and a heterozygous loss-of-function mechanism for 0819-mutant MAFB.
Combining our human and mouse data, we propose a threshold model for variable loss of MAFB function ( Figure 3C) . 
DISCUSSION
In this study, we use a combination of human genetics and an instructive mouse model to further our understanding of DRS. We establish MAFB as a new DRS disease gene, and find that MAFB mutations are present in ~1% of DRS probands in our cohort, making it a more common cause of DRS than the previously identified disease genes CHN1 (Miyake et al., 2008) , HOXA1 (Tischfield et al., 2005) , or SALL4 (Al- Baradie et al., 2002) . We propose that loss of MAFB function in developing hindbrain below a 50% threshold can cause both DRS and inner ear defects. We support this hypothesis through genotype-phenotype correlations in human and mouse. There are previous reports of heterozygous dominant-negative mutations causing more severe human phenotypes than heterozygous loss-of-function mutations in the same gene (Antony-Debre et al., 2015; Kondo et al., 2002) , but to our knowledge MAFB is the first such case to be supported by an animal model. Our findings also represent the first loss-of-function human mutations reported in MAFB and demonstrate allelic diversity in this gene (Walsh and Engle, 2010) . Hotspot missense mutations in the N-terminal transactivation domain were previously reported to cause multicentric carpotarsal osteolysis (Zankl et al., 2012) , and mutations in noncoding regions have been associated with cleft lip/cleft palate (Beaty et al., 2010) . These previously reported mutations are most likely gain-of-function since they do not disrupt the EHR, BR, or LZ domains of MAFB, and therefore act through different pathogenic mechanisms than the loss-of-function and dominant-negative mutations we have identified.
Although DRS was first described clinically in 1905 (Duane, 1996) , the developmental etiology remained unclear due to the lack of animal models that could reveal the underlying developmental neuropathology. Our work in Mafb knockout mice confirms human DRS pathology and demonstrates DRS pathogenesis in an animal model for the first time. Using a novel dissection technique to visualize the cranial nerves and extraocular muscles in the embryo, we elucidate the developmental mechanism of DRS by selectively disrupting the abducens nerve and observing secondary aberrant branching of the oculomotor nerve to innervate the LR muscle.
This provides the first experimental evidence to link proposed environmental causes of DRS, such as ischemia or teratogens (Parsa and Robert, 2013) , with established genetic causes of DRS, such as hindbrain malformations in HOXA1 patients (Tischfield et al., 2005) , into one common etiology. This has important clinical implications, since it suggests that both environmental and genetic disruptions of the abducens nerve in embryonic development can result in secondary aberrant innervation of the LR muscle by the oculomotor nerve, and offers insight into why DRS is far more common than a congenital sixth nerve palsy in the absence of globe retraction.
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The aberrant branching of the Mafb KO/KO oculomotor nerve at its two decision regions (Cheng et al., 2014 ) may explain the highly stereotypic co-contraction of the LR with the MR muscle, and the less frequent co-contraction of the LR with the SR and IR muscles, as reported by human electromyography (Huber, 1974; Strachan and Brown, 1972) . At its proximal decision region, the oculomotor nerve divides into superior and inferior divisions, and axons destined for any of its innervated muscles could be rerouted to form the small branches that aberrantly innervate the LR muscle in DRS. In particular, misdirection of a subset of superior division axons normally destined for the SR would account for the rare reports of LR and SR muscle co-contraction. In
Mafb KO/KO embryos, we find that most of the aberrant innervation arises from the distal decision region; here, axon rerouting could account for co-contraction of the LR with the MR or IR muscles. Thus, it is likely that the extraocular muscles ensure their innervation in early development by secreting shared guidance factors that induce nerve branching and directional growth along defined trajectories, and that the oculomotor and abducens axons compete for these guidance factors at two specific decision regions. Moreover, because co-contraction of the LR with the MR muscle is the most common aberrant innervation pattern in DRS, extraocular muscle innervation may also be programmed along the horizontal and vertical axes.
EXPERIMENTAL PROCEDURES
Clinical data and mutation screening. See Supplemental Experimental Procedures.
Mafb knockout mice. Mafb WT/flox mice were generously provided from the laboratory of Lisa
Goodrich at Harvard Medical School (Yu et al., 2013) . These were crossed to ubiquitously expressing EIIa-Cre mice to knock out Mafb. Mafb WT/KO mice were used for heterozygous crosses. Mafb KO/KO mice were used for embryonic studies but die at birth due to respiratory defects (Blanchi et al., 2003) . DNA was extracted from embryonic yolk sac using Extracta DNA Prep (Quanta Biosciences) and used for genotyping with Mafb wildtype and KO primers (Table   S2 ). ISL MN :GFP reporter mice were generously provided from the laboratory of Samuel Pfaff at
The Salk Institute (Lewcock et al., 2007) , and crossed to Mafb mice to allow for visualization of motor axons in development.
Orbital dissections. E12.5 and E16.5 Mafb-ISL MN :GFP mouse embryos were fixed overnight in 4% PFA. Brain tissue around the orbit was dissected away, leaving the distal cranial nerves and EOMs intact. The orbits were incubated with anti-actin α-smooth muscle-Cy3 antibody (SigmaAldrich) for 3 days at 4°C. After washing x3 with PBS, the orbits were further dissected and flat mounted in 70% glycerol and 1% 1M KOH in PBS. Images were acquired using a Zeiss LSM 710 laser scanning confocal microscope and Zen software (Zeiss). Images were processed with Imaris software (Bitplane). N > 3 were used for each experiment.
Whole mount immunohistochemistry. E11.5 Mafb-ISL MN :GFP mouse embryos were prepared as described previously (Huber et al., 2005) . Embryos were stained with mouse antineurofilament (clone 2H3, Developmental Studies Hybridoma Bank) at 1:500 and GFP tag antibody Alexa Fluor 488 conjugate (Thermo Fisher Scientific) at 1:500 as primaries, and goat anti-mouse Alexa Fluor 594 conjugate (Thermo Fisher Scientific) at 1:1000 as a secondary.
Embryos were cleared with BABB and placed into a custom designed holding chamber for confocal imaging. N > 3 were used for each experiment.
Cell culture, transfection, and DNA expression. See Supplemental Experimental Procedures.
Western blot and Luciferase assay. See Supplemental Experimental Procedures.
Statistical analyses. Data were analyzed in GraphPad Prism. One-way ANOVA was used to measure differences in relative fold activation. Error bars report standard error of the mean. 
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